![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/gold/t24_au_en_usoz_2.gif)
![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/silver/t24_ag_en_usoz_2.gif)
Landmark Depression Treatment Studies to be presented by CNS Response Inc. (CNSO.OB) at U.S. Psychiatric and Mental Health Congress
QualityStocks (November 3rd, 2009) Writes:
CNS Response Inc. has developed a data analysis capability that, when paired with a non-invasive EEG, analyzes a patient’s brain waves and compares those results to a patient outcome database, generating an rEEG report that allows psychiatrists to create personalized medication regimens for the patient.
According to the company, depression costs U.S. employers $83 billion annually; more than half of these costs are associated with treatment-resistant depression. Individuals with treatment-resistant depression cost $8,500 more per year than patients with ordinary depression. Through various studies, rEEG is the first objective, physiology-based, personalized medical technologies proven to efficiently and consistently enable psychiatrists to determine the right treatment for patients.
CNS Response today announced that Charles DeBattista, D.M.H, M.D., will present the results of a recent landmark study of rEEG at the U.S. Psychiatric and Mental Health Congress. The study proved rEEG effective at predicting medication response approximately 65 percent of the time.
...ceo, Charles DeBattista;, CNS Response Inc;, Congress, Control Group, Daniel Hoffman, Depression Treatment, George Carpenter, Investing Lessons, president and Chief Medical Officer, Small & Micro Cap, Stanford University Medical Center, STAR*D treatment algorithm, treatment algorithm, United States, USD
No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.